AGLE - Aeglea BioTherapeutics GAAP EPS of -$1.00 beats by $0.02 revenue of $18.73M beats by $1.33M
Aeglea BioTherapeutics press release (NASDAQ:AGLE): FY GAAP EPS of -$1.00 beats by $0.02. Revenue of $18.73M beats by $1.33M. As of December 31, 2021, the company had available cash, cash equivalents, marketable securities and restricted cash of $95.0 million
For further details see:
Aeglea BioTherapeutics GAAP EPS of -$1.00 beats by $0.02, revenue of $18.73M beats by $1.33M